SARAH MUTINSKY — Lobbyist Profile | Poliscope

SARAH MUTINSKY

Filings

Clients

Firms

Years active

2017–2026

Associated filing income

$1,360,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
AMERICA'S ESSENTIAL HOSPITALS	48	2017–2026

Lobbying firms

Firm	Filings	Years
EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)	48	2017–2026

Bills explicitly cited in this lobbyist’s assigned issues (4)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1628

American Health Care Act of 2017

Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

Open original LDA filing ↗

Cited source text

Health coverage, American Health Care Act (H.R. 1628), Health Care Freedom Act (H.R. 1628) Medicaid Medicaid Disproportionate Share Hospital Program 340B Drug Discount Program

H.R. 1628

American Health Care Act of 2017

Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

Open original LDA filing ↗

Cited source text

Health coverage, American Health Care Act (H.R. 1628), Better Care Reconciliation Act (H.R. 1628) Medicaid Medicaid Disproportionate Share Hospital Program 340B Drug Discount Program Medicare Hospital Payment

Original LDA source filings (48)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2026 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Health Care Access

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2026 · second_quarter · Q2

Firm income: —

Source: Senate LDA

Show 44 more original filings

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2025 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Health Care Access

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2025 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Health Care Access

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2025 · first_quarter · 1A

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Health Care Access

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2025 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Health Care Access

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2024 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Healthcare access Healthcare cybersecurity

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2024 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Healthcare access Healthcare cybersecurity

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2024 · second_quarter · 2A

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Healthcare access Healthcare workforce development

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2024 · second_quarter · 2A

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Healthcare access Healthcare workforce development

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2024 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Healthcare access Healthcare workforce development

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2024 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2024 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2023 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2023 · third_quarter · 3A

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2023 · third_quarter · Q3

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Hospital Anti-trust Issues

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2023 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program Funding support for hospitals Hospital Anti-trust Issues

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2023 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program COVID-related provider relief Funding support for hospitals

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2022 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program COVID-related provider relief Funding support for hospitals

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2022 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program COVID-related provider relief Funding support for hospitals

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2022 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program COVID-related provider relief Funding support for hospitals

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2022 · first_quarter · 1A

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid payment policies 340B Drug Discount Program COVID-related provider relief Funding support for hospitals

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2022 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Drug pricing policy Medicaid hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2021 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Drug pricing policy Medicaid hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2021 · third_quarter · Q3

Firm income: $15,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Drug pricing policy Medicaid hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2021 · second_quarter · Q2

Firm income: $15,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Drug pricing policy Medicaid hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2021 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Drug pricing policy Medicaid hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2020 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Medicaid financing Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2020 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Medicaid financing Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2020 · second_quarter · 2A

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Medicaid financing Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2020 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Medicaid financing Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2020 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Medicaid financing Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2019 · fourth_quarter · Q4

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Drug pricing policy Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2019 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Drug pricing policy Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2019 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Drug pricing policy Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2019 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid DSH 340B Drug Discount Program Drug pricing policy Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2018 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid 340B Drug Discount Program Medicare hospital payments Drug pricing policy

Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2018 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid 340B Drug Discount Program Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2018 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid 340B Drug Discount Program Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2018 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Medicaid Medicaid Disproportionate Share Hospital Program 340B Drug Discount Program Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2017 · fourth_quarter · Q4

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Health coverage, Graham-Cassidy Amendment (H.R. 1628) Medicaid Medicaid Disproportionate Share Hospital Program 340B Drug Discount Program Medicare hospital payments

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2017 · third_quarter · Q3

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Health coverage, American Health Care Act (H.R. 1628), Health Care Freedom Act (H.R. 1628) Medicaid Medicaid Disproportionate Share Hospital Program 340B Drug Discount Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2017 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Health coverage, American Health Care Act (H.R. 1628), Better Care Reconciliation Act (H.R. 1628) Medicaid Medicaid Disproportionate Share Hospital Program 340B Drug Discount Program Medicare Hospital Payment

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2017 · first_quarter · 1A

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Health care coverage, American Health Care Act (H.R. 1628) Medicaid Medicaid Disproportionate Share Hospital Program 340B Drug Discount Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2017 · first_quarter · 1A

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Disproportionate Share Hospital Program, 340B Drug Discount Program, Medicaid Reform, Medicare Reimbursement

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICA'S ESSENTIAL HOSPITALS via EYMAN PARTNERS LLC (FKA EYMAN ASSOCIATES PC)

2017 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Disproportionate Share Hospital Program, 340B Drug Discount Program, Medicaid Reform, Medicare Reimbursement

Filing targets: HOUSE OF REPRESENTATIVES, SENATE